Blood test may predict hip fracture outcomes in seniors

NCT ID NCT07350785

Recruiting now Knowledge-focused Sponsor: National and Kapodistrian University of Athens Source: ClinicalTrials.gov ↗

First seen Jan 22, 2026 · Last updated May 21, 2026 · Updated 15 times

Summary

This study looks at whether a blood test marker called Monocyte Distribution Width (MDW) can help predict serious complications and survival in older adults with hip fractures. About 100 patients aged 65 and older will be followed after surgery to track infections, hospital stays, and recovery. The goal is to find a simple way to identify high-risk patients early and improve their care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Laboratory for Research of the Musculoskeletal System
RECRUITING

Kifissia, Attica, 14561, Greece

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

HIP FRACTURE OSTEOPOROTIC HIP FRACTURE SEPSIS